Third Rock Closes First Fund

Third Rock Ventures has closed its debut fund with $378 million in capital commitments. The Boston-based firm will focus on early-stage life sciences opportunities. It was founded by four ex-Millennium Pharma executives, including former Millennium CEO Mark Levin, who had been a partner with Mayfield Fund until 1994.